1 option
Biomarkers in heart disease / edited by James A. de Lemos.
Holman Biotech Commons RC683.5.C5 B56 2008
Available
- Format:
- Book
- Series:
- AHA clinical series
- The AHA clinical series
- Language:
- English
- Subjects (All):
- Biochemical markers--Diagnostic use.
- Biochemical markers.
- Heart--Diseases--Molecular diagnosis.
- Heart.
- Heart Diseases--blood.
- Heart Diseases--diagnosis.
- Biomarkers--blood.
- Predictive Value of Tests.
- Risk Assessment--methods.
- Heart--Diseases.
- Molecular diagnosis.
- Medical Subjects:
- Heart Diseases--blood.
- Heart Diseases--diagnosis.
- Biomarkers--blood.
- Predictive Value of Tests.
- Risk Assessment--methods.
- Physical Description:
- xii, 238 pages : illustrations ; 24 cm.
- Place of Publication:
- Malden, Mass. : Blackwell Pub., 2008.
- Summary:
- Although the potential of biomarkers to enhance cardiovascular care is extremely bright, the challenge facing clinicians is determining how current and future biomarkers should be used in patient care, which is a fundamentally different process from early marker discovery. Biomarkers in Heart Disease is the first title in the AHA Clinical Series and is aimed at meeting the needs of clinicians, providing cardiologists, internists, emergency physicians, laboratorians, and other healthcare providers with a clear understanding of the role of biomarkers in contemporary cardiovascular medicine.
- This book covers both the strengths and pitfalls of currently available markers, and provides information on the most promising biomarkers that are likely to impact practice in the next few years. It is divided into four parts, organized around clinical scenarios rather than individual biomarkers: biomarkers for the evaluation and management of patients with suspected acute and chronic ischemic heart disease, heart failure diagnosis and monitoring, the increasingly important area of population screening, where the field is moving in the future. This book will help the practicing physician decide which biomarkers to measure, when to measure them, how to interpret the results, and how to make decisions based on the test result.
- Contents:
- Protocols for diagnosing myocardial infarction / James McCord
- Troponin and other markers of necrosis for risk stratification in patients with acute coronary syndromes / Thomas E. Noel and Michael C. Kontos
- Challenges interpreting cardiac troponin values / Fred S. Apple
- Natriuretic peptides and inflammatory markers for risk stratification in patients with ischemic heart disease / Torbjørn Omland and Torgun Wæhre
- Novel markers in patients with suspected acute coronary syndromes / Renato D. Lópes, Mark Chan, and L. Kristin Newby
- Use of natriuretic peptides in the diagnosis of heart failure / Abelardo Martinez-Rumayor and James L. Januzzi
- Biomarkers for risk stratification in patients with heart failure / W.H. Wilson Tang
- Natriuretic peptides for disease monitoring in patients with chronic heart failure / Richard W. Troughton and A. Mark Richards
- C-reactive protein / Amit Khera
- Newer markers for population screening: focus on lipoprotein-related markers / Vijay Nambi, Ron C. Hoogeveen, and Christie Ballantyne
- Moving towards personalized medicine / David A. Morrow, Marc S. Sabatine, and James A. de Lemos.
- Notes:
- "American Heart Association."
- Includes bibliographical references and index.
- ISBN:
- 9781405175715
- 1405175710
- OCLC:
- 182913266
- Online:
- Contributor biographical information
- Publisher description
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.